# FDA recall D-0152-2018

> **Fresenius Kabi USA, LLC** · Class I · drug recall initiated 2017-10-27.

## Product

Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 76045-001-20

## Reason for recall

Labeling: Label MIX-UP.  Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0152-2018
- **Recalling firm:** Fresenius Kabi USA, LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-10-27
- **Report date:** 2018-01-10
- **Termination date:** 2020-10-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilson, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0152-2018

## Citation

> AI Analytics. FDA recall D-0152-2018. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0152-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*